Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03762603

Does Supplementing of Quadriceps Strength With Exoskeleton After Total Knee Arthroplasty in High Risk Population Reduce Transfer to Extended Care Facility (ECF)

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

This study involves an exoskeleton which is believed to increase quadriceps muscle strength in the rehabilitation phase after TKA and reduce the discharge the such patients in Extended care facility (ECF) . The purpose of this study is to access efficacy of the robotic exoskeleton device wrapped around the operated knee on patients

Conditions

Interventions

TypeNameDescription
DEVICERobotic exoskeleton deviceIt is a non invasive and non significant risk medical device which wraps around operated knee to support motion.

Timeline

Start date
2025-09-01
Primary completion
2025-12-20
Completion
2027-12-20
First posted
2018-12-04
Last updated
2025-04-11

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03762603. Inclusion in this directory is not an endorsement.